Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Non-cash Items (2022 - 2024)

Historic Non-cash Items for bioAffinity Technologies (BIAF) over the last 3 years, with Q1 2024 value amounting to $243097.0.

  • bioAffinity Technologies' Non-cash Items fell 1039.48% to $243097.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $243097.0, marking a year-over-year decrease of 1039.48%. This contributed to the annual value of $158332.0 for FY2023, which is 360.6% down from last year.
  • Per bioAffinity Technologies' latest filing, its Non-cash Items stood at $243097.0 for Q1 2024, which was down 1039.48% from $158332.0 recorded in Q4 2023.
  • bioAffinity Technologies' Non-cash Items' 5-year high stood at $647793.0 during Q3 2022, with a 5-year trough of $158332.0 in Q4 2023.
  • For the 3-year period, bioAffinity Technologies' Non-cash Items averaged around $287185.4, with its median value being $254225.0 (2023).
  • Within the past 5 years, the most significant YoY rise in bioAffinity Technologies' Non-cash Items was 360.6% (2023), while the steepest drop was 6075.52% (2023).
  • bioAffinity Technologies' Non-cash Items (Quarter) stood at $164255.0 in 2022, then dropped by 3.61% to $158332.0 in 2023, then skyrocketed by 53.54% to $243097.0 in 2024.
  • Its Non-cash Items was $243097.0 in Q1 2024, compared to $158332.0 in Q4 2023 and $254225.0 in Q3 2023.